NCT01864070: Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease |
|
|
| Withdrawn | 1 | 0 | US | TheraSphere, Everolimus, Afinitor, Zortress, RAD001, Phone Call | M.D. Anderson Cancer Center, BTG International Inc., Novartis Pharmaceuticals | Liver Cancer | 05/18 | | | |
